Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening Strategies and Implications for Management

Area of Science:

• Endocrinology
• Metabolic Disorders

Background:

• Diabetes mellitus (DM) and thyroid dysfunction (TD) frequently coexist, with higher prevalence of hypothyroidism and hyperthyroidism in type 2 diabetes mellitus (T2DM) patients.
• Thyroid hormones significantly influence glucose, lipid, and protein metabolism, potentially worsening glycemic control in T2DM.
• Current guidelines lack specificity regarding the frequency of thyroid function monitoring in T2DM patients.

Purpose of the Study:

• To highlight the intricate relationship between T2DM and TD.
• To emphasize the impact of thyroid hormones on glycemic control and diabetic complications.
• To underscore the need for integrated monitoring and management strategies.

Main Methods:

• Review of existing literature on the interplay between T2DM and TD.
• Analysis of the metabolic effects of thyroid hormones on glucose regulation.
• Examination of the influence of antidiabetic and antithyroid medications on both conditions.

Main Results:

• Hyperthyroidism and thyrotoxicosis can exacerbate hyperglycemia and increase diabetic complication risks in T2DM.
• T2DM can lead to reduced thyroid-stimulating hormone levels and impaired peripheral conversion of thyroxine (T4) to triiodothyronine (T3).
• Poorly controlled T2DM may contribute to thyroid tissue proliferation, nodule formation, and goiter.
• Certain antidiabetic drugs (sulfonylureas, pioglitazone, thiazolidinediones) and antithyroid drugs (methimazole) can negatively affect TD and T2DM, respectively.

Conclusions:

• Integrated monitoring, termed 'thyrovigilance' in T2DM and 'diabetovigilance' in TD, is necessary.
• Individualized care plans are crucial for managing patients with coexisting T2DM and TD.
• Further research is needed to establish clear monitoring guidelines.